Viral Infectious Diseases: Epidemiology and Prevention through Vaccination

Dear Colleagues,

Viral diseases represent some of the complex interactions between the three components of the causal epidemiologic triad: agent, host, and environment. Viral agents have been characterized by a substantial degree of heterogeneity. In particular, certain viral agents (e.g., measles, rubella) seem to have evolved to a stable state with relatively little genetic variation over time at the population level, and diseases due to these biological agents have proved highly controllable through vaccination. On the contrary, several RNA viruses (e.g., influenza and coronaviruses, including SARS CoV-2) are more prone to mutations than many DNA viruses. Past and current experience indicate that certain viral agents of this group have been proved as considerable health hazards and socio-economic disruptors (Great Flu of 1918 and COVID-19 pandemics). Furthermore, for several viral-related diseases, there are effective and safe vaccines available, but there is a need for seroprevalence studies and also for the continuous monitoring of vaccination coverage. Moreover, vaccine hesitancy is an important obstacle to the vaccination against viral diseases.

Therefore, this Special Issue of Infectious Disease Reports entitled “Viral Infectious Diseases: Epidemiology and Prevention through Vaccination” is being launched, and we look forward to receiving your submissions (case reports, original papers, and systematic reviews/meta-analyses). You are welcome to send short proposals for submissions of feature papers to our Editorial Office for evaluation.

Dr. George Rachiotis
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Infectious Disease Reports is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• viral infectious diseases
• epidemiology
• molecular epidemiology
• seroprevalence
• vaccination coverage
• vaccine hesitancy